Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Debt / NOTE 1.500% 6/1
-
Number of holders
-
26
-
Total 13F principal, excl. options
-
197,210,000
-
Principal change
-
-730,681
-
Total reported value, excl. options
-
$200,950,767
-
Value change
-
-$4,539,819
-
Number of buys
-
16
-
Number of sells
-
-15
-
Price
-
$1.01
Significant Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 as of Q1 2024
36 filings reported holding 46333XAH1 - IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 as of Q1 2024.
IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 has 26 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $197,210,000 of principal
.
Largest 10 bondholders include BRAIDWELL LP ($52,740,000 of principal), Linden Advisors LP ($37,640,000 of principal), D. E. Shaw & Co., Inc. ($21,500,000 of principal), MILLENNIUM MANAGEMENT LLC ($15,000,000 of principal), Balyasny Asset Management L.P. ($14,750,000 of principal), Wellesley Asset Management ($11,091,000 of principal), CAPSTONE INVESTMENT ADVISORS, LLC ($10,781,000 of principal), Calamos Advisors LLC ($9,500,000 of principal), CAMDEN ASSET MANAGEMENT L P /CA ($8,651,000 of principal), and SHENKMAN CAPITAL MANAGEMENT INC ($5,919,000 of principal).
This table shows the top 26 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.